Introduction
F ractures in a neonate commonly result from a genetic predisposition and birth trauma. A generalized defect in collagen/connective tissue manifests as osteogenesis imperfecta (OI), which remains the commonest cause of genetic osteoporosis. Approximately 1 in 20000 cases of OI are detectable during infancy [1] . We report 3 cases of OI detected in early neonatal period in a span of one year.
Case Report
Details of the 3 cases are given in Table 1 . All 3 babies were products of nonconsanguinous marriage. Pregnancy had to be terminated in case 2 because of antepartum hemorrhage. Serum alkaline phosphatase, radiological survey and cranial USG were carried out apart from routine investigations. The alkaline phophatase levels were 450IU/L, 380IU/L and 360 IU/L in case 1,2 and 3 respectively. All cases were managed conservatively with splinting and minimal handling. Cases 1 & 3 were regularly reviewed clinically for evidence of hearing deficit, respiratory and neurological complications till they were lost to follow up after 04 and 02 months respectively. Case 2 died at 34 weeks due to sepsis.
Discussion
OI is an inherited autosomal dominant disorder characterized by the triad of fragile bones, blue sclera and deafness [1] . Clinical picture, radiological evidence and positive family history form the basis of diagnosis and classification. Sillence classification is the commonest one used in prognostication -Type I is usually detected in childhood due to its mild phenotype, Type II is perinatally lethal, Type III is progressively deforming and Type IV is of variable severity [2] . Temporal profiling (Fig 1a) White Sclera (Fig 1c) 
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Marked osteopenia Mild osteopenia; Healing Mild osteopenia Narrow thorax Fractures -Ribs, humerus, radius fracture shaft femur with Fractures -right radius and ulna, ulna (Fig 1b) callus formation proximal end right femur (Fig 1d) Final diagnosis OI Type III OI Type III OI Type III / IV of the cases is vital since the phenotype in the early neonatal period may be similar between the various subtypes. A loss to follow up common in our population compounds the difficulties of subclassification and may account for underreporting of these cases. Congenital hypophosphatasia and battered baby syndromes are common differential diagnoses in the early neonatal period [3] . Decreased bone mass, disturbed organization and altered bone geometry resulting from abnormal collagen lead to bone fragility in OI. Molecular diagnosis depends on demonstration of abnormal incorporation of radioactive amino acids in collagen in fibroblast cultures. Genetic localization can be done by DNA probes [1] . Molecular genetics reveals at least seven discrete types -majority (Sillence Class I-IV) have mutations in one of the two genes encoding type I collagen; the recently recognized Types V-VII do not have such mutations. In two other forms, (Bruck, and osteoporosis -pseudoglioma syndromes) defects in other proteins have been characterized [4] .
Follow up includes a good orthopedic management and rehabilitation. Regular hearing assessment is vital for early detection of hearing deficit. Respiratory infections and neurological complications like basilar invagination and brainstem compression are frequent [1, 3] . Dentinogenesis imperfecta, a common association, important in subclassification becomes apparent only after a few months. Cutaneous and ligamentous laxity and occasional bleeding diathesis are also reported [5] .
No curative therapy exists and using bisphosphonates in order to reduce osteoclast mediated bone resorption has targeted increased bone turnover in OI. Cyclical intravenous pamidronate and calcitriol administration reduces bone pain and fracture incidence, with increased bone density and level of ambulation, with minimal side effects [4, 6] . Growth hormone therapy has also been tried with variable results depending on type of OI [7] . Gene therapy may be the answer in the future.
Genetic screening and counselling is of paramount importance since the risk of an affected individual passing the gene to the offspring is 50% and the recurrence risk for an apparently unaffected couple of having a subsequently affected offspring is 5-7 % [1] . Antenatally, lethality can be predicted at 14-16 weeks of gestation by ultrasonography with severe shortening of the long bones, femur length-abdominal circumference ratio of less than 0.16, hypoplastic thorax and marked bowing or fractures [1, 8] . Chorionic villous biopsy can be done for recurrent cases [1] . Fetal MRI using ultra fast imaging technique, half-Fourier single-shot turbo spinecho (HASTE) has been used to improve imaging conspicuity and spatial resolution [9] .
